Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SAMRAT PHARMA vs HINDUSTAN BIOSCIE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SAMRAT PHARMA HINDUSTAN BIOSCIE SAMRAT PHARMA/
HINDUSTAN BIOSCIE
 
P/E (TTM) x 4,683.0 265.4 1,764.4% View Chart
P/BV x 1.6 10.0 16.4% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 SAMRAT PHARMA   HINDUSTAN BIOSCIE
EQUITY SHARE DATA
    SAMRAT PHARMA
Mar-23
HINDUSTAN BIOSCIE
Mar-23
SAMRAT PHARMA/
HINDUSTAN BIOSCIE
5-Yr Chart
Click to enlarge
High Rs1,2506 22,321.4%   
Low Rs3323 10,278.6%   
Sales per share (Unadj.) Rs1,005.30.9 111,763.6%  
Earnings per share (Unadj.) Rs53.80 -137,918.9%  
Cash flow per share (Unadj.) Rs55.90 -163,715.7%  
Dividends per share (Unadj.) Rs1.000-  
Avg Dividend yield %0.10-  
Book value per share (Unadj.) Rs204.30.7 28,039.5%  
Shares outstanding (eoy) m3.0910.25 30.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.84.9 16.0%   
Avg P/E ratio x14.7-111.7 -13.2%  
P/CF ratio (eoy) x14.1-130.2 -10.9%  
Price / Book Value ratio x3.96.1 63.8%  
Dividend payout %1.90-   
Avg Mkt Cap Rs m2,44445 5,400.1%   
No. of employees `000NANA-   
Total wages/salary Rs m112 597.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m3,1069 33,692.6%  
Other income Rs m50-   
Total revenues Rs m3,1119 33,744.5%   
Gross profit Rs m2390 -85,453.6%  
Depreciation Rs m60 10,716.7%   
Interest Rs m120 30,800.0%   
Profit before tax Rs m2250 -59,289.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m590 196,666.7%   
Profit after tax Rs m1660 -41,577.5%  
Gross profit margin %7.7-3.1 -251.9%  
Effective tax rate %26.2-6.6 -398.0%   
Net profit margin %5.4-4.4 -122.0%  
BALANCE SHEET DATA
Current assets Rs m9869 11,466.9%   
Current liabilities Rs m52814 3,720.2%   
Net working cap to sales %14.8-60.6 -24.4%  
Current ratio x1.90.6 308.2%  
Inventory Days Days8946 0.9%  
Debtors Days Days602179,564,165 0.0%  
Net fixed assets Rs m17524 723.4%   
Share capital Rs m3121 150.7%   
"Free" reserves Rs m601-13 -4,605.4%   
Net worth Rs m6317 8,452.9%   
Long term debt Rs m011 0.0%   
Total assets Rs m1,16233 3,536.9%  
Interest coverage x19.3-8.5 -226.9%   
Debt to equity ratio x01.5 0.0%  
Sales to assets ratio x2.70.3 952.6%   
Return on assets %15.4-1.1 -1,389.3%  
Return on equity %26.3-5.4 -486.4%  
Return on capital %37.6-1.8 -2,077.8%  
Exports to sales %4.10-   
Imports to sales %83.30-   
Exports (fob) Rs m127NA-   
Imports (cif) Rs m2,587NA-   
Fx inflow Rs m1276 2,159.8%   
Fx outflow Rs m2,5870-   
Net fx Rs m-2,4606 -41,905.8%   
CASH FLOW
From Operations Rs m-94-1 18,874.0%  
From Investments Rs m-30NA-  
From Financial Activity Rs m961 19,198.0%  
Net Cashflow Rs m-280-  

Share Holding

Indian Promoters % 48.6 12.2 399.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.2 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 51.4 87.8 58.5%  
Shareholders   8,065 10,315 78.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SAMRAT PHARMA With:   SUN PHARMA    CIPLA    DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on SAMRAT PHARMA vs HINDUSTAN BIOSCIE

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

SAMRAT PHARMA vs HINDUSTAN BIOSCIE Share Price Performance

Period SAMRAT PHARMA HINDUSTAN BIOSCIE S&P BSE HEALTHCARE
1-Day -1.87% -1.89% 1.18%
1-Month -10.12% -24.16% -0.75%
1-Year -2.44% -13.38% 61.82%
3-Year CAGR 34.42% 34.35% 18.16%
5-Year CAGR 38.09% 50.47% 19.79%

* Compound Annual Growth Rate

Here are more details on the SAMRAT PHARMA share price and the HINDUSTAN BIOSCIE share price.

Moving on to shareholding structures...

The promoters of SAMRAT PHARMA hold a 48.6% stake in the company. In case of HINDUSTAN BIOSCIE the stake stands at 12.2%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of SAMRAT PHARMA and the shareholding pattern of HINDUSTAN BIOSCIE.

Finally, a word on dividends...

In the most recent financial year, SAMRAT PHARMA paid a dividend of Rs 1.0 per share. This amounted to a Dividend Payout ratio of 1.9%.

HINDUSTAN BIOSCIE paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of SAMRAT PHARMA, and the dividend history of HINDUSTAN BIOSCIE.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.